Anaveon raised €105M in a Series B round in Dec 2021. The company is based in Zurich, Switzerland. Investors in the round: Cowen Healthcare Investments, Forbion Capital Partners, Novartis Venture Fund and 3 others. Data as of 6 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
